Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma.
Published in Gastroenterology • Jun 1, 2015
Authors:,,
Joon Hyeok Lee
Jeong-Hoon Lee
Young-Suk Lim
Abstract
BACKGROUND & AIMS: No adjuvant therapy has been shown to extend the survival of patients with hepatocellular carcinoma (HCC) receiving curative treatment. We investigated whether injections of activated cytokine-induced killer (CIK) cells (CD3+/CD56+ and CD3+/CD56- T cells and CD3-/CD56+ natural kil...
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!